This sequence of events whereby increased levels of l NF appears in the serum of patients at an early stage of progressive neurological disease is consistent with the finding of Byrne [49] that l NF appears to be an early biomarker correlated with the rate of clinical progression of the autosomal dominant disease Huntington Disease (HD). The gene discussed is NFASC; the disease is nervous system disorder.